The Ensign Group (ENSG) Oppenheimer 36th Annual Healthcare MedTech & Services Conference summary

Business performance and growth

• Achieved consistent execution and broad-based occupancy growth across all markets, with improvements in labor fundamentals and retention.

• Enhanced ability to transition and improve underperforming buildings, accelerating operational improvements and enabling more aggressive expansion into new states.

• 2026 guidance projects a 15% revenue increase and 14% EPS growth, with organic growth expected across same-store (2–4%), transitioning (4–5%), and recently acquired (9–10%) segments.

• Guidance does not include potential acquisitions, which could impact revenue and EPS depending on the scale and turnaround needs.

Acquisition strategy and integration

• Acquisition environment remains strong with increased deal flow and attractive opportunities, though pricing is high and strategic rationale is emphasized for premium deals.

• Recent large acquisitions in Utah, California, Alaska, and Oregon have performed well, with rapid census and earnings growth.

• Integration model relies on breaking down large deals into manageable pieces with strong local leadership, enabling successful expansion into new geographies.

• Southeast U.S. is a focus for future expansion, with interest in Florida, Georgia, and North Carolina.

Leadership pipeline and talent

• Maintains a robust pipeline of administrators in training, ensuring leadership capacity for ongoing and future acquisitions.

• Attracts new talent due to organizational success and peer influence, keeping the leadership pool healthy.